Prognostic Value of Lung Ultrasound in ST Segment Elevation Acute Myocardial Infarction (LUS-AMI)

Summary

Participation Requirements

Description

LUS-AMI is an observational cohort prospective study that evaluates the prognostic value of lung ultrasound, specifically the number of B-lines, performed within the first 24 hours after and ST-segment elevation acute myocardial infarction, by an independent operator blinded to clinical outcomes and...

LUS-AMI is an observational cohort prospective study that evaluates the prognostic value of lung ultrasound, specifically the number of B-lines, performed within the first 24 hours after and ST-segment elevation acute myocardial infarction, by an independent operator blinded to clinical outcomes and off-line analysis by another independent operator also blinded to clinical outcomes. Follow-up is six months after STEMI and the primary outcome is a composite of any cause mortality, hospitalization secondary to cardiovascular disease (acute coronary syndrome, heart failure or stroke) or need for urgent coronary revascularization. Secondary outcomes are each event composing primary outcome separately, new onset heart failure during hospitalization, acute kidney injury during hospitalization, new onset clinically relevant arrythmia (atrial fibrillation, atrial flutter, ventricular tachycardia, ventricular fibrillation) or unexpected consultation secondary to heart failure.

Tracking Information